Ausgabe 1/2004
Inhalt (15 Artikel)
Hormone Sensitivity is Reflected in the Phospholipid Profiles of Breast Cancer Cell Lines
Marina Sterin, Jack S. Cohen, Israel Ringel
Elevated Expression of the Tumor Suppressing Protein p53 is Associated with the Presence of Mouse Mammary Tumor-Like env Gene Sequences (MMTV-like) in Human Breast Cancer
James S. Lawson, Dinh D. Tran, Caroline Ford, William D. Rawlinson
Estrogen and progesterone receptor isoforms: clinical significance in breast cancer
Suzanne AW Fuqua, Yukun Cui
Genetic Variants of the Sulfotransferase 1A1 and Breast Cancer Risk
Uwe Langsenlehner, Peter Krippl, Wilfried Renner, Babak Yazdani-Biuki, Tanja Eder, Gerald Wolf, Thomas C. Wascher, Bernhard Paulweber, Werner Weitzer, Hellmut Samonigg
Mutations of the p53 Gene and Loss of Heterozygosity at Chromosome 17p13.1 are Associated with Increased Survivin Expression in Breast Cancer
Naoki Tsuji, Kaori Furuse, Koichi Asanuma, Momoko Furuya, Kei Kondoh, Chinatsu Kamagata, Masateru Sasaki, Daisuke Kobayashi, Atsuhito Yagihashi, Hiroshi Takahashi, Naoki Watanabe
Overexpression of Bcl-xL in Human Breast Cancer Cells Enhances Organ-Selective Lymph Node Metastasis
Laura España, Yolanda Fernández, Nuria Rubio, Angels Torregrosa, Jeronimo Blanco, Angels Sierra
Quality of Life of Breast Cancer Survivors After a Recurrence: A Follow-Up Study
Sindy Oh, Lara Heflin, Beth E. Meyerowitz, Katherine A. Desmond, Julia H. Rowland, Patricia A. Ganz
Failure of High Risk Women to Produce Nipple Aspirate Fluid Does Not Exclude Detection of Cytologic Atypia in Random Periareolar Fine Needle Aspiration Specimens
Priyanka Sharma, Jennifer R. Klemp, Marie Simonsen, Chezna M. Welsko, Carola M. Zalles, Bruce F. Kimler, Carol J. Fabian
Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow
C. Schindlbeck, W. Janni, N. Shabani, B. Rack, B. Gerber, M. Schmitt, N. Harbeck, H. Sommer, S. Braun, K. Friese
Does Subjective Burden of Early Breast Cancer and its Treatment Affect Immune Measures During Adjuvant Therapy?
Marzio E.E. Sabbioni, Jürg Bernhard, Hans-Peter Siegrist, Shu-Fang Hsu Schmitz, Monica Castiglione Gertsch, Beat Thürlimann, Hervé Bonnefoi, Lucien Perey, Richard Herrmann, Aron Goldhirsch, Christoph Hürny
EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines
James M. Rae, Joshua O. Scheys, Kim M. Clark, Robert B. Chadwick, Michael C. Kiefer, Marc E. Lippman
The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human-Derived Breast Carcinoma Xenograft Models
Iduna Fichtner, Anne Monks, Curtis Hose, Malcolm F.G. Stevens, Tracey D. Bradshaw
Possible Association Between c-erbB-2 and Human Papillomavirus-16 in Breast Cancer Patients
Ozden Altundag, Kadri Altundag, Mehmet Gunduz